Clinical Diagnostics and Research Tools

  1. 23 Aug 2022  |  North America

    Frost Radar™: US Liquid Biopsy, 2022

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...

    $4,950.00

    Special Price $4,207.50 save 15 %

  2. 14 Mar 2022  |  North America

    Next-generation Diagnostics Outlook, 2022

    Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

    In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

    $4,950.00

    Special Price $3,712.50 save 25 %

  3. 01 Mar 2022  |  Europe

    European Clinical Laboratory Services Growth Opportunity

    Customer Experience Driven by New B2B and B2C Business Models

    Diagnostics is the backbone of the healthcare sector. According to a World Health Organization (WHO) study, although the segment accounts for less than 5% of hospital costs, its findings influence 60–70% of healthcare decision-making. Diagnostics helps to analyze medical conditions and guide patients toward the right medication, treatment, or sur...

    $2,450.00

    Special Price $1,837.50 save 25 %

  4. 28 Feb 2022  |  North America

    United States Clinical Laboratory Services Growth Opportunities

    Advanced Molecular Diagnostics and At-Home Testing are Growth Prerequisites

    The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to...

    $2,450.00

    Special Price $1,837.50 save 25 %

  5. 22 Feb 2022  |  North America

    United States Liquid Biopsy Growth Opportunities

    Non-invasive Liquid Biopsy Technology Shapes the Precision Diagnostics Landscape

    Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...

    $4,950.00

    Special Price $3,712.50 save 25 %

  6. 24 Nov 2021  |  Global

    Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies

    Need for Scalable, Reproducible, and Cost-Effective Manufacturing Processes Driving Growth Opportunities

    The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

    $4,950.00

    Special Price $3,712.50 save 25 %

  7. 08 Oct 2021  |  North America

    Global Tissue Diagnostics (TDx) Growth Opportunities

    Companion Diagnostics (CDx)-specific Advanced Staining and Anatomical Pathology Laboratory Information Systems (APLIS) to Drive Ma

    This research service provides an overview of the global TDx market and a 4-year forecast of it from 2021 to 2025. The market will reach $8,848.6 million in 2025, growing at a compound annual growth rate (CAGR) of 8.9% from 2020 to 2025. The advanced staining and anatomical pathology laboratory information management systems (APLIS) segments will g...

    $4,950.00

    Special Price $3,712.50 save 25 %

  8. 20 Sep 2021  |  North America

    Global In Vitro Diagnostics Market Outlook, 2021

    Personalized Diagnostics and Increased Healthcare Investment to Drive Market Growth Post COVID-19 Pandemic

    The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...

    $4,950.00

    Special Price $3,712.50 save 25 %

  9. 12 Aug 2021  |  North America

    Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...

    $4,950.00

    Special Price $3,712.50 save 25 %

  10. 30 Jun 2021  |  North America

    US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities

    Telegenetic Counseling to Revolutionize Access to Patient Care

    In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...

    $2,450.00

    Special Price $1,837.50 save 25 %